logo

For the Inventor, By the Inventor

Herstal, Belgium

Mdxhealth, Sa

USPTO Granted Patents = 12


Trademarks = 16

Forward Citations = 43

Loading Chart...
Loading Chart...

21 inventors (with patents filed for the assignee):

goldMedal Wim Van Criekinge (6 out of 7 patents)

silverMedal Katja Bierau (4 out of 8 patents)

bronzeMedal Ilse Vlassenbroeck (3 out of 3 patents)

4.  Joost Louwagie (2 out of 6 patents)

5.  Isabelle Renard (2 out of 2 patents)

6.  Valerie Deregowski (2 out of 2 patents)

7.  Luc Dehaspe (2 out of 2 patents)

8.  G Bea A Wisman (2 out of 2 patents)

9.  Ate G J Van Der Zee (2 out of 2 patents)

10.  E M D Schuuring (2 out of 2 patents)

11.  Manon Van Engeland (1 out of 5 patents)

12.  Arjan Griffioen (1 out of 7 patents)

13.  Manon Adriaan De Bruine (1 out of 5 patents)

14.  Gontran Brichard (1 out of 5 patents)

15.  Maarten Penning (1 out of 5 patents)


12 patents:

1. 11767563 - Method for predicting and treating clinically significant prostate cancer (2023-09-26),
2. 10119166 - Methods and kits for identifying and adjusting for bias in sequencing of polynucleotide samples (2018-11-06),
3. 10113202 - Method for determining the methylation status of the promoter region of the TWIST1 gene in genomic DNA from bladder cells (2018-10-30),
4. 10053724 - Methylation detection of the MGMT promoter (2018-08-21),
5. 10041128 - Methylation of the EPB41L3 gene or the promoter of the EPB41L3 gene in a test sample comprising cervical cells (2018-08-07),
6. 9605312 - Methods of detecting mutations in BRAF and epigenetic changes (2017-03-28),
7. 9388471 - Methylation of the GATA4 gene in urine samples as a marker for bladder cancer detection (2016-07-12),
8. 9371569 - Detection and prognosis of cervical cancer (2016-06-21),
9. 9322065 - Methods for determining methylation of the TWIST1 gene for bladder cancer detection (2016-04-26),
10. 9050280 - Methylation detection of MGMT (2015-06-09),
11. 8969046 - Methods for detecting epigenetic modifications (2015-03-03),
12. 8481700 - Detection of mage-A expression (2013-07-09),
Company Overview
Mdxhealth, Sa is a biotechnology company based in Herstal, Belgium, specializing in the development of innovative molecular diagnostic solutions for cancer. The organization focuses on providing advanced tests that assist in the diagnosis and management of prostate cancer, among other malignancies. By leveraging cutting-edge research and technology, Mdxhealth aims to improve patient outcomes through personalized medicine, enabling healthcare providers to make informed treatment decisions tailored to individual patient needs.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

12 Patents

#5 in Herstal

#228 in Belgium

#48,209 in the World

Herstal, BE
Herstal, Belgium

Mdxhealth, Sa

Forward Citations = 43

21 inventors:

goldMedal Wim Van Criekinge (6 out of 7 patents)

silverMedal Katja Bierau (4 out of 8 patents)

bronzeMedal Ilse Vlassenbroeck (3 out of 3 patents)

4.  Joost Louwagie (2 out of 6 patents)

5.  Isabelle Renard (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Mdxhealth, Sa. Retrieved from https://idiyas.com/company/mdxhealth-sa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…